Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fear of Cancer Recurrence Therapy (FORT): Turkish Cultural Adaptation and Implementation Project

NCT06676228 is registered in ClinicalTrials.gov with Maltepe University as lead sponsor.

NCT NCT06676228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06676228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fear of Cancer Recurrence Therapy (FORT): Turkish Cultural Adaptation and Implementation Project
Lead sponsor
Maltepe University
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2024
Completion date
September 26, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, cancer coping, depression not otherwise specified, fear of cancer recurrence, intolerance of uncertainty, quality of life (qol), self efficacy